QUICK MARKET SUMMARY: CONSUMER: 🔸 Colgate ( $CL): New $5B buyback, dividend to $0.52. 🔸 $NCLH: Upgraded to Equal Weight (Morgan Stanley). 🔸 Lennar ( $LEN): Q1 EPS $2.14 (est. $1.73), rev $7.63B (est. $7.49B); Q2 orders 22.5k-23.5k, deliveries 19.5k-20.5k. 🔸 Nike ( $NKE): Q3 EPS $0.54 (est. $0.28), rev $11.3B (est. $11.03B); guides Q4 rev down mid-teens. 🔸 $NIO: Q4 rev $2.7B (est. $2.79B), EV deliveries up 45%; Q1 guide: 41k-43k vehicles, rev $1.69B-$1.76B (est. $2.48B). 🔸 Torrid ( $CURV): Q4 sales -6.1% y/y; guides Q1 sales $264M-$274M (est. $279M), EBITDA below estimates. 🔸 Target ( $TGT): Files $1B note offering due 2035. Energy/Industrials/Materials: 🔸 FedEx ( $FDX): Q3 EPS $4.51 (miss), rev $22.2B (beat); cuts FY25 guidance. 🔸 Nucor ( $NUE): Q1 EPS guide $0.50-$0.60 (est. $1.09); sees lower steel product prices. 🔸 Planet Labs ( $PL): Q4 loss -$0.08 (est. -$0.02), rev $61.6M; Q1 guide below est. 🔸 U.S. Steel ( $X): Q1 EBITDA $125M (in line), EPS loss guided larger than est. 🔸 BP ( $BP): Elliott pushes for cost cuts, possible board changes (Reuters). Healthcare: 🔸 Assembly Bio ( $ASMB): Files $250M mixed shelf. 🔸 Editas ( $EDIT): CFO stepping down. 🔸 Foghorn ( $FHTX): Files $100M shelf. 🔸 J&J ( $JNJ): Plans $55B investment in U.S. manufacturing/research. 🔸 Maravai ( $MRVI): Guides Q1 rev $43M-$45M (est. $63M). 🔸 Vor Bio ( $VOR): Files $350M shelf. Tech/Media/Telecom: 🔸 Micron ( $MU): Q2 EPS $1.56 (beat), rev $8.05B; Q3 guide above est. 🔸 Luminar ( $LAZR): Sees slower Q1, FY25 rev growth 10%-20%. 🔸 Quantum ( $QUBT): Q4 loss -$0.47 (miss), rev $62k; chip foundry launch in 2025. 🔸 Super Micro ( $SMCI): Upgraded to Neutral (JPM), price target raised to $45.

#Downgrades - Dec 05, 2024 • $ABBV: Daiwa Securities Downgrades to Neutral from Buy - PT $180 • $AEO: JPMorgan Downgrades to Neutral from Overweight - PT $23 (from $27) • $ALLY: Wolfe Research Downgrades to Peerperform from Outperform • $AMAT: Morgan Stanley Downgrades to Underweight from Equalweight - PT $164 (from $179) • $CHWY: BNP Paribas Downgrades to Neutral from Outperform - PT $30 • $CNX: JPMorgan Downgrades to Underweight from Neutral - PT $37 (from $31) • $DVN: JPMorgan Downgrades to Neutral from Overweight - PT $191 • $F: Wolfe Research Downgrades to Underperform from Peerperform • $FOUR: Benchmark Downgrades to Hold from Buy • $FWONA: Seaport Global Securities Downgrades to Neutral from Buy • $GRAB: HSBC Downgrades to Hold from Buy - PT $5.50 (from $4.25) • $MRVI : Goldman Sachs Downgrades to Sell from Neutral - PT $4.25 (from $7) • $NAUT: Goldman Sachs Downgrades to Sell from Neutral - PT $1.75 (from $2.25) • $NCNO: Piper Sandler Downgrades to Neutral from Overweight - PT $38 • $OTIS: Barclays Downgrades to Underweight from Equalweight - PT $94 • $PB: Wolfe Research Downgrades to Peerperform from Outperform • $PFG: Morgan Stanley Downgrades to Underweight from Equalweight - PT $80 (from $86) • $RLMD: Mizuho Downgrades to Neutral from Outperform - PT $1 (from $23) • $ROP: Barclays Downgrades to Underweight from Overweight - PT $569 (from $625) • $SBRA: Mizuho Downgrades to Neutral from Outperform - PT $20 • $SM: JPMorgan Downgrades to Neutral from Overweight - PT $16 (from $15) • $VCYT: Goldman Sachs Downgrades to Neutral from Buy - PT $37 (from $38)